This activity is provided by PVI, PeerView Institute for Medical Education in partnership with Healthtree Foundation for Multiple Myeloma. The overall goal of the proposed educational initiative is to provide clinicians with updated, clinically relevant information supporting the use of anti-BCMA therapies in MM, including practice guidelines, clinical trial and real-world evidence, and resources from HealthTree Foundation for Multiple Myeloma, to illustrate the central role that anti-BCMA options can play in the patient therapeutic journey. To achieve this goal, we will develop an integrated, CME/MOC/AAPA-certified live and enduring Clinical Consults educational platform in collaboration with HealthTree Foundation for Multiple Myeloma.